Section
This article examines the prevalent coprescription of enzyme-inducing antiseizure medications (ASMs) and susceptible hormonal contraceptives among US Medicaid beneficiaries with epilepsy, highlighting patient risk factors and implications f
This study explores how the choice of diabetes self-care location at school affects glycemic control in children with Type 1 diabetes, highlighting restroom use as a risk factor for poorer outcomes and emphasizing the need for supportive sc
An expert consensus provides practical, evidence-informed guidance for clinicians to protect people with cardiovascular disease from rising heat extremes, focusing on prevention, medication review, cooling strategies, and health-system prep
A multidisciplinary consensus offers patient-facing, evidence-based safety statements and symptom-specific guidance to replace routine medical clearance and reduce barriers to organised physical activity for people with long-term conditions
Adolescents who sustain mild traumatic brain injury (mTBI) face a significantly higher risk of developing mental health disorders over the subsequent year, influenced by factors such as sex, socioeconomic status, and prior psychiatric histo
This study uncovers molecular subtypes of salivary adenoid cystic carcinoma based on genomic and transcriptomic analyses, introducing a novel copy number variation (CNV)-based classification that improves prognostic accuracy and could refin
A large randomized trial assessing whether adding a blood-based multicancer early-detection test to usual care reduces late-stage cancer diagnoses found no significant difference in stage III or IV cancers but observed a trend toward fewer
Silk-hyaluronic acid injection laryngoplasty offers a safe, effective office-based treatment for glottic insufficiency, showing comparable voice improvement to hyaluronic acid alone but with higher rates of operative revisions.
A large retrospective study shows no benefit of routine postoperative antibiotics after appendectomy for acute appendicitis, even with intra-abdominal fluid; highlights risk factors driving infections instead.
The RCOG 2026 update stresses single embryo transfer, improved freezing, counselling and funding to prevent IVF multiple pregnancy and its harms while maintaining live-birth rates.
This international multicenter study reveals low immediate mortality after pediatric first variceal hemorrhage, with outcomes strongly influenced by underlying diagnosis, disease severity, and center-specific practices.
This study links higher physical activity levels with slower cognitive and motor decline in Parkinson’s disease, highlighting the importance of sustained activity engagement.
This study demonstrates that polygenic risk scores (PRS) independently predict type 2 diabetes risk in Japanese individuals, and healthy lifestyles can mitigate this risk even among genetically predisposed people, enhancing personalized pre
Over-the-counter analgesic use after concussion is linked to reduced symptom severity and faster return to unrestricted play, highlighting their potential role in postconcussion management.
A 2024 multicenter study in Amhara, Ethiopia found nearly 80% of stroke survivors experienced fall-related injuries, with older age, rural residency, and walking/turning activities as key risk factors.
This study identifies immune biomarkers, including proliferative CD8+ T cells, CD68+ macrophages, and PD-1 expression, which differentiate high-risk oral tongue epithelial dysplasia and may improve patient risk stratification beyond convent
An open-label trial demonstrates the safety and potential efficacy of ChrimsonR-based optogenetic therapy combined with specialized goggles to enhance light sensitivity in patients with advanced retinitis pigmentosa, offering promising aven
Telomere length serves as an independent prognostic marker for progression-free survival in chronic lymphocytic leukemia patients treated with venetoclax-based regimens, highlighting its role in risk stratification during the modern targete
A phase II trial shows that adding the bispecific antibody glofitamab to polatuzumab-R-CHP achieves a 95% complete response rate and durable remission with minimal cytokine release syndrome in high-risk diffuse large B-cell lymphoma.
This article reviews the KOMET-007 trial evaluating ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated AML, highlighting promising remission rates and manageable safety.
